NCT00004895View on ClinicalTrials.gov

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Stromal TumorNausea and VomitingOvarian CancerPancreatic CancerPeritoneal Cavity CancerSmall Intestine Cancer
Interventions
DRUG

octreotide acetate

Trial Locations (1)

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004895 - Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter